1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for PURDUE PHARMA LLP

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to pharmaceuticall and biological products; Federal Food, Drug and Cosmetic Act (21USC 9); Drug Safety; Food and Drug Administration Amendments Act of 2007 (Public Law No.l10-85); FDA Globalization Act (HR 759)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 759 (111th)

Pharmacy PHA

Controlled Drug Substances Act (21 USC 13)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.